The Muscular Dystrophy Association (MDA) just announced that they are providing $3.2 million to the ALS Therapy Development Institute (ALS TDI) to support ALS TDI’s preclinical research efforts. The funds are being contributed from the Augie’s Quest campaign, which benefits the MDA’s worldwide ALS research program. Dr. Steve Perrin, CEO and CSO of ALS TDI, said “Our partnership with MDA has helped us to establish a foundation that paves the way for new discoveries, better powering our research that may lead to effective treatments for patients today.” Since 2007, ALS TDI has received over $31 million in funding from the MDA. Learn about how ALS TDI has used these funds to further ALS research by clicking the link below.
Click here to read more.Share this: